South Africa’s Health Minister Dr Aaron Motsoaledi addresses misinformation in Parliament, stating that the HIV prevention injection lenacapavir is safe and does not cause HIV infection or cancer. According to the account, Motsoaledi rejects claims circulating about the medicine’s effects, and emphasizes that available information shows it is suitable for HIV prevention.
He says the injection’s side effects are mild and generally manageable. Motsoaledi’s comments focus on reassuring lawmakers and the public after concerns were raised that the drug could lead to HIV or cancer. The intervention highlights the government’s position on the safety of lenacapavir and its use in HIV prevention programmes.
Overall, the reporting reflects a response to disputed allegations rather than new clinical findings, with the minister presenting safety assurances and characterizing any adverse effects as limited in severity. The matter is framed as an effort to correct misinformation and maintain confidence in an HIV prevention medicine used or promoted for public health purposes.
